Details for New Drug Application (NDA): 203691
The generic ingredient in TEMOZOLOMIDE is temozolomide. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the temozolomide profile page.
Summary for 203691
| Tradename: | TEMOZOLOMIDE |
| Applicant: | Amneal Pharms |
| Ingredient: | temozolomide |
| Patents: | 0 |
Pharmacology for NDA: 203691
| Mechanism of Action | Alkylating Activity |
Suppliers and Packaging for NDA: 203691
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203691 | ANDA | Amneal Pharmaceuticals LLC | 65162-801 | 65162-801-14 | 1 BOTTLE in 1 CARTON (65162-801-14) / 14 CAPSULE in 1 BOTTLE |
| TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203691 | ANDA | Amneal Pharmaceuticals LLC | 65162-801 | 65162-801-51 | 1 BOTTLE in 1 CARTON (65162-801-51) / 5 CAPSULE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
| Approval Date: | May 8, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
| Approval Date: | May 8, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | May 8, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
